Stereotactic Body Radiotherapy vs. Moderately Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer: A Randomized Clinical Trial
Importance The treatment of prostate cancer with radiotherapy is evolving. How quickly radiotherapy can be delivered, and the relative risks and benefits of such a treatment, is of significant public interest. Objective To determine whether stereotactic body radiotherapy (SBRT) was superior to moderately-hypofractionat...